Clario partners with CellCarta to streamline trial tissue, sample handling

2023-09-28

并购临床研究

Clario partners with CellCarta to streamline trial tissue, sample handling

Preview

来源: FierceBiotech

Clario and CellCarta are teaming up to make the collection and digitization of tissue and other clinical trial samples much easier.

Clinical trial tech firm Clario has joined forces with CellCarta to improve the way tissue and other samples are handled during trials.

The collaboration will also encompass the digitization of the information gathered across several therapeutic areas including oncology, hepatology and gastroenterology, Clario said in a Sept. 26 press release.

CellCarta is known for its work in integrated sample management and specialized lab services. Its sample management kit provides provisioning and sample accessioning, processing, digitization and quality control. The joined-up offering will also allow the automated and secure transfer of digitized pathology images to the Clario portal, avoiding delays related to manual download and upload.

Financial terms of the deal weren’t disclosed.

“This partnership advances Clario's ability to support histopathology studies, providing our customers with full visibility for biopsy sample logistics and significantly accelerates delivery of centralized assessments for eligibility and efficacy endpoints,” Joyce Suhy, Ph.D., Clario’s executive vice president for medical imaging and specialty solutions, said in the release.

As part of its plans to reevaluate trial sector changes to generate new opportunities, Clario sold its eClinical technology to Miami-based CRO Sitero in August for an undisclosed price. The sale was described by Clario CEO Chris Fikry, M.D., at the time as “the best path forward.”

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。

机构